Immunosenescence and inflamm-aging as two sides of the same coin: Friends or Foes?

Frontiers in Immunology

Volumn 8, Issue JAN, 2018, Pages

  Fulop, Tamas ^a   Larbi, Anis ^b   Dupuis, Gilles ^a   Page, Aurélie Le ^a   Frost, Eric H ^a   Cohen, Alan A ^a   Witkowski, Jacek M ^c   Franceschi, Claudio ^d  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b AGENCY FOR SCIENCE   (Singapore)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Healthspan; Immune adaptation; Immunometabolism; Immunoremodeling; Immunosenescence; Inflamm aging; Longevity

Indexed keywords

CD45RA ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 1; INTERLEUKIN 33; INTERLEUKIN 7; INTERLEUKIN 8; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PATTERN RECOGNITION RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; AGING; ALZHEIMER DISEASE; ANTIGENICITY; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; EPIGENETICS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; IMMUNOSENESCENCE; INFLAMMATION; INFLUENZA VACCINATION; INNATE IMMUNITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; REVIEW;

EID: 85040515054     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01960     Document Type: Review

References (126)

1. Zierer J, Menni C, Kastenmüller G, Spector TD. Integration of 'omics' data in aging research: from biomarkers to systems biology. Aging Cell (2015) 14(6):933-44. doi:10.1111/acel.12386
2. Jazwinski SM, Yashin AI. Aging and health-a systems biology perspective. introduction. Interdiscip Top Gerontol (2015) 40:VII-XII
3. Cohen AA. Complex systems dynamics in aging: new evidence, continuing questions. Biogerontology (2016) 17(1):205-20. doi:10.1007/s10522-015-9584-x
4. Fulop T, McElhaney J, Pawelec G, Cohen AA, Morais JA, Dupuis G, et al. Frailty, inflammation and immunosenescence. Interdiscip Top Gerontol Geriatr (2015) 41:26-40. doi:10.1159/000381134
5. Pawelec G. Does the human immune system ever really become 'senescent'? F1000Res (2017) 6(F1000 Faculty Rev):1323. doi:10.12688/f1000research.11297.1
6. Franceschi C, Salvioli S, Garagnani P, de Eguileor M, Monti D, Capri M. Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity. Front Immunol (2017) 8:982. doi:10.3389/fimmu.2017.00982
7. Xu W, Larbi A. Markers of T cell senescence in humans. Int J Mol Sci (2017) 18(8):E1742. doi:10.3390/ijms18081742
8. Fulop T, Dupuis G, Baehl S, Le Page A, Bourgade K, Frost E, et al. From inflamm-aging to immune-paralysis: a slippery slope during aging for immune-adaptation. Biogerontology (2016) 17(1):147-57. doi:10.1007/s10522-015-9615-7
9. Goronzy JJ, Fang F, Cavanagh MM, Qi Q, Weyand CM. Naïve T cell maintenance and function in human ageing. J Immunol (2015) 194:4073-80. doi:10.4049/jimmunol.1500046
10. Pawelec G. Hallmarks of human 'immunosenescence': adaptation or dysregulation? Immun Ageing (2012) 9:15. doi:10.1186/1742-4933-9-15
11. Yanes RE, Gustafson CE, Weyand CM, Goronzy JJ. Lymphocyte generation and population homeostasis throughout life. Semin Hematol (2017) 54:33-8. doi:10.1053/j.seminhematol.2016.10.003
12. Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol (2012) 24:331-41. doi:10.1016/j.smim.2012.04.008
13. Montgomery RR, Shaw AC. Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol (2015) 98(6):937-43. doi:10.1189/jlb.5MR0315-104R
14. Fülöp T Jr, Fóris G, Wórum I, Leövey A. Age-dependent alterations of Fc gamma receptor-mediated effector functions of human polymorphonuclear leucocytes. Clin Exp Immunol (1985) 61(2):425-32
15. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 908:244-54. doi:10.1111/j.1749-6632.2000.tb06651.x
16. Müller L, Fülöp T, Pawelec G. Immunosenescence in vertebrates and invertebrates. Immun Ageing (2013) 10(1):12. doi:10.1186/1742-4933-10-12
17. Rivera A, Siracusa MC, Yap GS, Gause WC. Innate cell communication kick-starts pathogen-specific immunity. Nat Immunol (2016) 17(4):356-63. doi:10.1038/ni.3375
18. Kaufmann SH, Dorhoi A. Molecular determinants in phagocyte-bacteria interactions. Immunity (2016) 44(3):476-91. doi:10.1016/j.immuni.2016.02.014
19. Vidya MK, Kumar VG, Sejian V, Bagath M, Krishnan G, Bhatta R. Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals. Int Rev Immunol (2017) 13:1-17. doi:10.1080/08830185.2017.1380200
20. Kufer TA, Nigro G, Sansonetti PJ. Multifaceted functions of NOD-like receptor proteins in myeloid cells at the intersection of innate and adaptive immunity. Microbiol Spectr (2016) 4(4):429-36. doi:10.1128/microbiolspec.MCHD-0021-2015
21. Barik S. What really rigs up RIG-I? J Innate Immun (2016) 8(5):429-36. doi:10.1159/000447947
22. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A (2012) 109:17537-42. doi:10.1073/pnas.1202870109
23. Netea MG, van der Meer JW. Trained immunity: an ancient way of remembering. Cell Host Microbe (2017) 21(3):297-300. doi:10.1016/j.chom.2017.02.003
24. Tieri P, Grignolio A, Zaikin A, Mishto M, Remondini D, Castellani GC, et al. Network, degeneracy and bow tie. Integrating paradigms and architectures to grasp the complexity of the immune system. Theor Biol Med Model (2010) 11(7):32. doi:10.1186/1742-4682-7-32
25. Bektas A, Schurman SH, Sen R, Ferrucci L. Human T cell immunosenescence and inflammation in aging. J Leukoc Biol (2017) 102(4):977-88. doi:10.1189/jlb.3RI0716-335R
26. Molony RD, Malawista A, Montgomery RR. Reduced dynamic range of antiviral innate immune responses in aging. Exp Gerontol (2017) S0531-5565(17):30483-7. doi:10.1016/j.exger.2017.08.019
27. Byun HO, Lee YK, Kim JM, Yoon G. From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes. BMB Rep (2015) 48(10):549-58. doi:10.5483/BMBRep.2015.48.10.122
28. Biagi E, Candela M, Fairweather-Tait S, Franceschi C, Brigidi P. Aging of the human metaorganism: the microbial counterpart. Age (Dordr) (2012) 34(1):247-67. doi:10.1007/s11357-011-9217-5
29. Bauer ME, Fuente Mde L. The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence. Mech Ageing Dev (2016) 158:27-37. doi:10.1016/j.mad.2016.01.001
30. Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and 'Garb-aging'. Trends Endocrinol Metab (2017) 28(3):199-212. doi:10.1016/j.tem.2016.09.005
31. van der Heijden CD, Noz MP, Joosten LAB, Netea MG, Riksen NP, Keating ST. Epigenetics and trained immunity. Antioxid Redox Signal (2017). doi:10.1089/ars.2017.7310
32. Bekkering S, Blok BA, Joosten LA, Riksen NP, van Crevel R, Netea MG. In vitro experimental model of trained innate immunity in human primary monocytes. Clin Vaccine Immunol (2016) 23(12):926-33. doi:10.1128/CVI.00349-16
33. Calabrese EJ, Dhawan G, Kapoor R, Iavicoli I, Calabrese V. What is hormesis and its relevance to healthy aging and longevity? Biogerontology (2015) 16(6):693-707. doi:10.1007/s10522-015-9601-0
34. Martucci M, Ostan R, Biondi F, Bellavista E, Fabbri C, Bertarelli C, et al. Mediterranean diet and inflammaging within the hormesis paradigm. Nutr Rev (2017) 75(6):442-55. doi:10.1093/nutrit/nux013
35. Ostan R, Bucci L, Capri M, Salvioli S, Scurti M, Pini E, et al. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation (2008) 15(4-6):224-40. doi:10.1159/000156466
36. Arai Y, Martin-Ruiz CM, Takayama M, Abe Y, Takebayashi T, Koyasu S, et al. Inflammation, but not telomere length, predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians. EBioMedicine (2015) 2(10):1549-58. doi:10.1016/j.ebiom.2015.07.029
37. Lowe D, Horvath S, Raj K. Epigenetic clock analyses of cellular senescence and ageing. Oncotarget (2016) 7(8):8524-31. doi:10.18632/oncotarget.7383
38. Garagnani P, Bacalini MG, Pirazzini C, Gori D, Giuliani C, Mari D, et al. Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell (2012) 11(6):1132-4. doi:10.1111/acel.12005
39. Horvath S, Pirazzini C, Bacalini MG, Gentilini D, Di Blasio AM, Delledonne M, et al. Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring. Aging (Albany NY). (2015) 7(12):1159-70. doi:10.18632/aging.100861
40. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2007) 128(1):92-105. doi:10.1016/j.mad.2006.11.016
41. Morrisette-Thomas V, Cohen AA, Fülöp T, Riesco é, Legault V, Li Q, et al. Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev (2014) 139:49-57. doi:10.1016/j.mad.2014.06.005
42. Monti D, Ostan R, Borelli V, Castellani G, Franceschi C. Inflammaging and human longevity in the omics era. Mech Ageing Dev (2017) 165(Pt B):129-38. doi:10.1016/j.mad.2016.12.008
43. Fülöp T, Dupuis G, Witkowski JM, Larbi A. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin (2016) 68(2):84-91
44. Geeraerts X, Bolli E, Fendt SM, Van Ginderachter JA. Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front Immunol (2017) 15(8):289. doi:10.3389/fimmu.2017.00289
45. Rose G, Santoro A, Salvioli S. Mitochondria and mitochondria-induced signalling molecules as longevity determinants. Mech Ageing Dev (2017) 165(Pt B):115-28. doi:10.1016/j.mad.2016.12.002
46. Calabrese V, Santoro A, Monti D, Crupi R, Paola RD, Latteri S, et al. Aging and Parkinson's disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med (2017) 115:80-91. doi:10.1016/j.freeradbiomed.2017.10.379
47. Agrawal A, Agrawal S, Gupta S. Role of dendritic cells in inflammation and loss of tolerance in the elderly. Front Immunol (2017) 8:896. doi:10.3389/fimmu.2017.00896
48. Johnston-Carey HK, Pomatto LC, Davies KJ. The immunoproteasome in oxidative stress, aging, and disease. Crit Rev Biochem Mol Biol (2015) 51(4):268-81. doi:10.3109/10409238.2016.1172554
49. Fulop T, Le Page A, Fortin C, Witkowski JM, Dupuis G, Larbi A. Cellular signaling in the aging immune system. Curr Opin Immunol (2014) 29:105-11. doi:10.1016/j.coi.2014.05.007
50. Bryl E, Witkowski JM. Decreased proliferative capability of CD4+ cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T cells. Exp Gerontol (2004) 39(4):587-95. doi:10.1016/j.exger.2003.10.029
51. Rider DA, Sinclair AJ, Young SP. Oxidative inactivation of CD45 protein tyrosine phosphatase may contribute to T lymphocyte dysfunction in the elderly. Mech Ageing Dev (2003) 124(2):191-8. doi:10.1016/S0047-6374(02)00120-3
52. Das A, Ranganathan V, Umar D, Thukral S, George A, Rath S, et al. Effector/memory CD4 T cells making either Th1 or Th2 cytokines commonly co-express T-bet and GATA-3. PLoS One (2017) 12(10):e0185932. doi:10.1371/journal.pone.0185932
53. Mittrücker HW, Visekruna A, Huber M. Heterogeneity in the differentiation and function of CD8? T cells. Arch Immunol Ther Exp (Warsz) (2014) 62(6):449-58. doi:10.1007/s00005-014-0293-y
54. Golubovskaya V, Wu L. Different subsets of T cells, memory, effector functions, and CAR-T Immunotherapy. Cancers (Basel) (2016) 8(3):E36. doi:10.3390/cancers8030036
55. Larbi A, Fulop T. From 'truly naïve' to 'exhausted senescent' T cells: when markers predict functionality. Cytometry A (2014) 85(1):25-35. doi:10.1002/cyto.a.22351
56. Kim C, Fang F, Weyand CM, Goronzy JJ. The life cycle of a T cell after vaccination-where does immune ageing strike? Clin Exp Immunol (2017) 187(1):71-81. doi:10.1111/cei.12829
57. Tu W, Rao S. Mechanisms underlying T cell immunosenescence: aging and Cytomegalovirus infection. Front Microbiol (2016) 7:2111. doi:10.3389/fmicb.2016.02111
58. Appay V, Sauce D. Naive T cells: the crux of cellular immune aging? Exp Gerontol (2014) 54:90-3. doi:10.1016/j.exger.2014.01.003
59. Nguyen THO, Sant S, Bird NL, Grant EJ, Clemens EB, Koutsakos M, et al. Perturbed CD8+ T cell immunity across universal influenza epitopes in the elderly. J Leukoc Biol (2017). doi:10.1189/jlb.5MA0517-207R
60. Pawelec G. Immunosenescence and cancer. Biogerontology (2017) 18:717-21. doi:10.1007/s10522-017-9682-z
61. Gattinoni L, Speiser DE, Lichterfeld M, Bonini C. T memory stem cells in health and disease. Nat Med (2017) 23(1):18-27. doi:10.1038/nm.4241
62. Pawelec G. Immunosenenescence: role of cytomegalovirus. Exp Gerontol (2014) 54:1-5. doi:10.1016/j.exger.2013.11.010
63. Derhovanessian E, Maier AB, Hähnel K, Zelba H, de Craen AJ, Roelofs H, et al. Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people. Age (Dordr) (2013) 35(4):1387-99. doi:10.1007/s11357-012-9425-7
64. Solana R, Tarazona R, Aiello AE, Akbar AN, Appay V, Beswick M, et al. CMV and immunosenescence: from basics to clinics. Immun Ageing (2012) 9(1):23. doi:10.1186/1742-4933-9-23
65. Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol (2012) 24:507-11. doi:10.1016/j.coi.2012.04.002
66. Söderberg-Nauclér C, Fornara O, Rahbar A. Cytomegalovirus driven immunosenescence-an immune phenotype with or without clinical impact? Mech Ageing Dev (2016) 158:3-13. doi:10.1016/j.mad.2016.06.005
67. McElhaney JE, Garneau H, Camous X, Dupuis G, Pawelec G, Baehl S, et al. Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes. BMJ Open Diabetes Res Care (2015) 3(1):e000140. doi:10.1136/bmjdrc-2015-000140
68. Bajwa M, Vita S, Vescovini R, Larsen M, Sansoni P, Terrazzini N, et al. CMV-specific T-cell responses at older ages: broad responses with a large central memory component may be key to long-term survival. J Infect Dis (2017) 215(8):1212-20. doi:10.1093/infdis/jix080
69. Campisi J, Robert L. Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol (2014) 39:45-61. doi:10.1159/000358899
70. Effros RB. Replicative senescence: the final stage of memory T cell differentiation? Curr HIV Res (2003) 1:153-65. doi:10.2174/1570162033485348
71. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 6(12):2853-68. doi:10.1371/journal.pbio.0060301
72. Rao SG, Jackson JG. SASP: tumor suppressor or promoter? Yes! Trends Cancer (2016) 2:676-87. doi:10.1016/j.trecan.2016.10.001
73. Capece D, Verzella D, Tessitore A, Alesse E, Capalbo C, Zazzeroni F. Cancer secretome and inflammation: the bright and the dark sides of NF-κB. Semin Cell Dev Biol (2017). doi:10.1016/j.semcdb.2017.08.004
74. Campisi J. Cellular senescence and lung function during aging. Yin and Yang. Ann Am Thorac Soc (2016) 13(Suppl_5):S402-6. doi:10.1513/AnnalsATS.201609-703AW
75. Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol (2015) 15(8):486-99. doi:10.1038/nri3862
76. Akbar AN, Henson SM, Lanna A. Senescence of T lymphocytes: implications for enhancing human immunity. Trends Immunol (2016) 37(12):866-76. doi:10.1016/j.it.2016.09.002
77. Henson SM, Macaulay R, Riddell NE, Nunn CJ, Akbar AN. Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8+ T-cell proliferation by distinct pathways. Eur J Immunol (2015) 45:1441-51. doi:10.1002/eji.201445312
78. Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med (2016) 8:328rv324. doi:10.1126/scitranslmed.aad7118
79. Zarour HM. Reversing T-cell dysfunction and exhaustion in cancer. Clin Cancer Res (2016) 22:1856-64. doi:10.1158/1078-0432.CCR-15-1849
80. Elias R, Karantanos T, Sira E, Hartshorn KL. Immunotherapy comes of age: immune aging & checkpoint inhibitors. J Geriatr Oncol (2017) 8:229-35. doi:10.1016/j.jgo.2017.02.001
81. Daste A, Domblides C, Gross-Goupil M, Chakiba C, Quivy A, Cochin V, et al. Immune checkpoint inhibitors and elderly people: a review. Eur J Cancer (2017) 82:155-66. doi:10.1016/j.ejca.2017.05.044
82. Hurez V, Padrón áS, Svatek RS, Curiel TJ. Considerations for successful cancer immunotherapy in aged hosts. Clin Exp Immunol (2017) 187:53-63. doi:10.1111/cei.12875
83. MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol (2013) 31:259-83. doi:10.1146/annurev-immunol-032712-095956
84. Michalek RD, Rathmell JC. The metabolic life and times of a T-cell. Immunol Rev (2010) 236:190-202. doi:10.1111/j.1600-065X.2010.00911.x
85. Kouidhi S, Elgaaied AB, Chouaib S. Impact of metabolism on T-cell differentiation and function and cross talk with tumor microenvironment. Front Immunol (2017) 8:270. doi:10.3389/fimmu.2017.00270
86. Liu H, Yang H, Chen X, Lu Y, Zhang Z, Wang J, et al. Cellular metabolism modulation in T lymphocyte immunity. Immunology (2014). doi:10.1111/imm.12321
87. Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science (2016) 354:481-4. doi:10.1126/science.aaf6284
88. Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic instruction of immunity. Cell (2017) 169(4):570-86. doi:10.1016/j.cell.2017.04.004
89. Henson SM, Lanna A, Riddell NE, Franzese O, Macaulay R, Griffiths SJ, et al. p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+T cells. J Clin Invest (2014) 124(9):4004-16. doi:10.1172/JCI75051
90. Akbar AN. The convergence of senescence and nutrient sensing during lymphocyte ageing. Clin Exp Immunol (2017) 187(1):4-5. doi:10.1111/cei.12876
91. Weyand CM, Goronzy JJ. Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc (2016) 13(Suppl_5):S422-8. doi:10.1513/AnnalsATS.201602-095AW
92. Yu M, Li G, Lee WW, Yuan M, Cui D, Weyand CM, et al. Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci U S A (2012) 109(15):E879-88. doi:10.1073/pnas.1109797109
93. Li G, Yu M, Lee WW, Tsang M, Krishnan E, Weyand CM, et al. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med (2012) 18:1518-24. doi:10.1038/nm.2963
94. Chakraborty AK, Weiss A. Insights into the initiation of TCR signaling. Nat Immunol (2014) 15:798-807. doi:10.1038/ni.2940
95. Porciello N, Tuosto L. CD28 costimulatory signals in T lymphocyte activation: emerging functions beyond a qualitative and quantitative support to TCR signalling. Cytokine Growth Factor Rev (2016) 28:11-9. doi:10.1016/j.cytogfr.2016.02.004
96. Dustin ML, Depoil D. New insights into the T cell synapse from single molecule techniques. Nat Rev Immunol (2011) 11:672-84. doi:10.1038/nri3066
97. Larbi A, Dupuis G, Khalil A, Douziech N, Fortin C, Fülöp T Jr. Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging. Cell Signal (2006) 18(7):1017-30. doi:10.1016/j.cellsig.2005.08.016
98. Turner JE, Brum PC. Does regular exercise counter T cell immunosenescence reducing the risk of developing cancer and promoting successful treatment of malignancies? Oxid Med Cell Longev (2017)2017:4234765. doi:10.1155/2017/4234765
99. Weltevrede M, Eilers R, de Melker HE, van Baarle D. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review. Exp Gerontol (2016) 77:87-95. doi:10.1016/j.exger.2016.02.005
100. Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, et al. The age-related increase in low-grade systemic inflammation (inflammaging) is not driven by cytomegalovirus infection. Aging Cell (2012) 11(5):912-5. doi:10.1111/j.1474-9726.2012.00849.x
101. van der Geest KS, Abdulahad WH, Tete SM, Lorencetti PG, Horst G, Bos NA, et al. Aging disturbs the balance between effector and regulatory CD4+ T cells. Exp Gerontol (2014) 60:190-6. doi:10.1016/j.exger.2014.11.005
102. Frasca D, Diaz A, Romero M, Blomberg BB. The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations. Vaccine (2016) 34(25):2834-40. doi:10.1016/j.vaccine.2016.04.023
103. Sonntag WE, Ungvari Z. GeroScience: understanding the interaction of processes of aging and chronic diseases. Age (Dordr) (2016) 38(5-6):377-8. doi:10.1007/s11357-016-9953-7
104. Franceschi C, Garagnani P. Suggestions from geroscience for the genetics of age-related diseases. PLoS Genet (2016) 12(11):e1006399. doi:10.1371/journal.pgen.1006399
105. Sierra F. The emergence of geroscience as an interdisciplinary approach to the enhancement of health span and life span. Cold Spring Harb Perspect Med (2016) 6(4):a025163. doi:10.1101/cshperspect.a025163
106. Yang Y, Li T, Nielsen ME. Aging and cancer mortality: dynamics of change and sex differences. Exp Gerontol (2012) 47:695-705. doi:10.1016/j.exger.2012.06.009
107. Weinberger B, Schirmer M, Matteucci Gothe R, Siebert U, Fuchs D, Grubeck-Loebenstein B. Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. PLoS One (2013) 8(12):e82967. doi:10.1371/journal.pone.0082967
108. Merani S, Pawelec G, Kuchel GA, McElhaney JE. Impact of aging and Cytomegalovirus on immunological response to influenza vaccination and infection. Front Immunol (2017) 8:784. doi:10.3389/fimmu.2017.00784
109. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol (2014) 29:38-42. doi:10.1016/j.coi.2014.03.008
110. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med (2015) 372(22):2087-96. doi:10.1056/NEJMoa1501184
111. Fulop T, Larbi A, Witkowski JM, McElhaney J, Loeb M, Mitnitski A, et al. Aging, frailty and age-related diseases. Biogerontology (2010) 11(5):547-63. doi:10.1007/s10522-010-9287-2
112. Hurez V, Padrón á, Svatek RS, Curiel TJ. Considerations for successful cancer immunotherapy in aged hosts. Exp Gerontol (2017). doi:10.1016/j.exger.2017.10.002
113. Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu YL, et al. New advances in CMV and immunosenescence. Exp Gerontol (2014) 55:54-62. doi:10.1016/j.exger.2014.03.020
114. Santoro A, Ostan R, Candela M, Biagi E, Brigidi P, Capri M, et al. Gut microbiota changes in the extreme decades of human life: a focus on centenarians. Cell Mol Life Sci (2017). doi:10.1007/s00018-017-2674-y
115. Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, et al. Gut microbiota and extreme longevity. Curr Biol (2016) 26(11):1480-5. doi:10.1016/j.cub.2016.04.016
116. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 56:M146-57. doi:10.1093/gerona/56.3.M146
117. Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci (2007) 62:738-43. doi:10.1093/gerona/62.7.738
118. Wu IC, Lin CC, Hsiung CA. Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. Biomedicine (Taipei) (2015) 5(1):1. doi:10.7603/s40681-015-0001-1
119. Cohen AA, Milot E, Li Q, Bergeron P, Poirier R, Dusseault-Bélanger F, et al. Detection of a novel, integrative aging process suggests complex physiological integration. PLoS One (2015) 10(3):e0116489. doi:10.1371/journal.pone.0116489
120. Dusseault-Belanger F, Cohen AA, Hivert MF, Courteau J, Vanasse A. Validating metabolic syndrome through principal component analysis in a medically diverse, realistic cohort. Metab Syndr Relat Disord (2013) 11(1):21-8. doi:10.1089/met.2012.0094
121. Li Q, Wang S, Milot E, Bergeron P, Ferrucci L, Fried LP, et al. Homeostatic dysregulation proceeds in parallel in multiple physiological systems. Aging Cell (2015) 14(6):1103-12. doi:10.1111/acel.12402
122. Milot E, Morissette-Thomas V, Li Q, Fried LP, Ferrucci L, Cohen AA. Trajectories of physiological dysregulation predicts mortality and health outcomes in a consistent manner across three populations. Mech Ageing Dev (2014) 14(1-142):56-63. doi:10.1016/j.mad.2014.10.001
123. Arbeev KG, Cohen AA, Arbeeva LS, Milot E, Stallard E, Kulminski AM, et al. Optimal versus realized trajectories of physiological dysregulation in aging and their relation to sex-specific mortality risk. Front Public Health (2016) 4:3. doi:10.3389/fpubh.2016.00003
124. Szarc vel Szic K, Declerck K, Vidakovic M, Vanden Berghe W. From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition? Clin Epigenetics (2015) 7:33. doi:10.1186/s13148-015-0068-2
125. Quach A, Levine ME, Tanaka T, Lu AT, Chen BH, Ferrucci L, et al. Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging (Albany NY) (2017) 9(2):419-46. doi:10.18632/aging.101168
126. Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis. Ageing Res Rev (2017) 40:31-44. doi:10.1016/j.arr.2017.08.003